University of Texas at Dallas (UT Dallas)

Cells called corneal keratocytes are innately programmed to come to the rescue if the eye is injured. This natural healing process sometimes fails, however, resulting in scarring and blindness. Scientists are still trying to understand why.
New research by University of Texas at Dallas bioengineer Dr. David Schmidtke aims to help solve that mystery. Schmidtke and his team have demonstrated a technique in the lab for fabricating tiny strands of collagen called fibrils to facilitate further research on the eye's repair process. The method was detailed in a new study published in the December issue of the journal Biomedical Microdevices.
The study was funded in part by a $1.8 million, five-year National Institutes of Health grant that Schmidtke received last summer to develop new ways to study the eye's healing mechanisms -- knowledge that may lead to new therapies and treatments.
"How keratocytes repair tissue and why, in some cases, they leave scar tissue, is not well understood," said Schmidtke, professor of bioengineering in the Erik Jonsson School of Engineering and Computer Science. "We came up with a way to mimic an injury model, so we can look at how the cells respond when there is a wound."
Dr. Matthew Petroll, professor of ophthalmology and chair of the biomedical engineering graduate program at UT Southwestern Medical Center, initially approached Schmidtke for help in finding a new way to study how the patterning and topography of fibrils can influence corneal cell behavior. These threadlike structures are arranged in a crisscross pattern in the eye and serve as a path to guide keratocytes to an injury.
The UT Dallas research draws on Schmidtke's expertise in microfluidic devices, which are palm-sized pieces of transparent plastic that contain small channels about the size of a strand of human hair. He is using these devices to fabricate the fibrils. Schmidtke's research team, which includes undergraduate and graduate students, injects collagen into the channels. The collagen polymerizes as it flows through the channels, resulting in aligned fibrils that are similar in structure to the collagen fibrils that are present in corneal tissue.
Schmidtke is working with Dr. Victor Varner, assistant professor of bioengineering at UT Dallas, who is focusing on how keratocytes sense the level of stiffness or softness in the fibrils with which they interact. The researchers plan to study how fibrils' density, elasticity and dimensionality affect keratocytes. For example, keratocytes behave differently on aligned collagen fibrils compared to randomly oriented collagen fibrils, Schmidtke said.
The research could help develop therapies to reduce corneal scarring and guide efforts to engineer tissue replacements. The models also could be used in other fields where researchers need to study cell patterning and behavior. Schmidtke conducts his research at UT Dallas and in lab space at UT Southwestern.
"The collaboration with UT Southwestern, and having research lab space there, has been a big benefit to applying engineering tools to biomedical questions," he said.
A high-throughput microfluidic method for fabricating aligned collagen fibrils to study Keratocyte behavior
Kevin H. Lam, Pouriska B. Kivanany, Kyle Grose, Nihan Yonet-Tanyeri, Nesreen Alsmadi, Victor D. Varner, W. Matthew Petroll, David W. Schmidtke
Biomedical Microdevices (December 2019) 21:99
DOI: 10.1007/s10544-019-0436-3
Contact information:
UT Dallas professor of bioengineering
david.schmidtke@utdallas.edu
Phone: 972-883-5238
UT Dallas assistant professor of bioengineering
vdv@utdallas.edu
Phone: 972-883-7203
UT Southwestern Medical Center professor of ophthalmology
PetrollLab@utsouthwestern.edu

Mecwins has described its AVAC technology, which labels target proteins with plasmonic nanoparticles and counts each one individually by dark-field micro-spectrophotometry. The AVAC Analyzer reaches femtogram-range sensitivity.
Hesperos has received an SBIR Phase II grant (R44AI197758) from NIAID to expand its Malaria-on-a-Chip platform, adding support for viable, replicating parasite strains and predictive PK/PD modeling.

UCLA researchers have shown that briefly squeezing a cell's nucleus for milliseconds can loosen tightly packed DNA and make CRISPR activation far more effective at reprogramming cell identity. After mapping which genomic regions opened, they aimed guide RNAs at those sites, raising the share of mouse skin cells converted to neurons from about 3% to 10%. Adding a priming step that activated Oct4 pushed conversion to roughly 40%.
This week in nanotech
$108.5M raised
7 funding rounds · 39 deals tracked
New products
DLS-1 Mass Spectrometer for Fusion Gas AnalysisHiden Analytical Featured
Nion-compatible In Situ STEM Holders for Electrical BiasingHummingbird Scientific Featured
Hold Down & Release Mechanisms (HDRM) REACT – 5KN, 15KN and 35KN space qualified resettable mechanismsARQUIMEAMarket insights
Last 30 days: Quantum Technologies drew the most money: $3.17B.
Money raised per month
Behind the deal
Who invested in Photon Bridge’s $11.2M Series A?
See the investors with Insights Pro →